OLANDER CLINICAL CONSULTING 1 ApS: Financial statements 2024
CVR: 35532900
OLANDER CLINICAL CONSULTING 1 ApS (CVR 35532900) has filed annual accounts for 2024. In 2024, the company reported revenue of DKK 0 and a net result of DKK 30,979 compared with DKK 23,757 the year before. Equity amounted to DKK 138,682. The solvency ratio was 92.2%.
- Revenue
- 0 kr.
- Gross Profit
- -1,004 kr.
- Profit/Loss
- 30,979 kr.
- Equity
- 138,682 kr.
- Total Assets
- 150,362 kr.
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2024 | 0 | -1 t. | 31 t. | 139 t. | - |
| 2023 | 0 | -8 t. | 24 t. | 108 t. | - |
| 2022 | - | -7 t. | 30 t. | 114 t. | - |
| 2021 | - | -7 t. | 29 t. | 109 t. | - |
| 2020 | - | -6 t. | 23 t. | 104 t. | - |
How creditworthy is OLANDER CLINICAL CONSULTING 1 ApS?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2024
OLANDER CLINICAL CONSULTING 1 ApS has published its annual report for 2023. Revenue came to DKK 0, and the net result was DKK 23,757.
About OLANDER CLINICAL CONSULTING 1 ApS
OLANDER CLINICAL CONSULTING 1 ApS is a Danish company of the type Anpartsselskab based in Snekkersten, founded in 2013. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The management consists of Birgitte Aae Olander. The company is owned by Birgitte Aae Olander. The company has 0 employees. In 2025, the company reported a gross profit of DKK 38,365 and a net result of DKK 28,455 compared with DKK 30,979 the year before. Equity amounted to DKK 167,137.
